Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Identification of pericyte biomarkers in aqueous and vitreous humor reflecting diabetic retinopathy severity

Stephanie Hartouni; Irene Tom; Daphne Yang; Ricardo Lamy; Joshua Wu; Jay M. Stewart; Michael Chang

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3618 – A0073. doi:

ARVO Annual Meeting Abstract June 2020

Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA)

Dante Joseph Pieramici; Arshad M. Khanani; Flavia Brunstein; Hao Chen; Ling Ma; Katie Maass; Irene Tom; Lee Honigberg; Eric C Strauss; Phillip Lai

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1942. doi:

ARVO Annual Meeting Abstract June 2020

Identification of DKK3 as an Ocular Pharmacodynamic Biomarker for anti-HtrA1 in a Phase 1 study for Geographic Atrophy Secondary to Age-related macular degeneration

Irene Tom; Victoria Pham; Kenneth J Katschke; Wei Li; Wei-Ching Liang; Johnny Guiterrez; Andrew Ah Young; Shadi Eshghi; Michael Chang; Phillip Lai; Menno van Lookeren Campagne; Daniel Kirchhofer; Amos Baruch; Jennie Lill; Lee Honigberg

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4306. doi:

ARVO Annual Meeting Abstract July 2018

Determining ocular HtrA1 activity and inhibition using novel activity based probe

Irene Tom; Johnny Gutierrez; Kenneth J Katschke; Isabel Figueroa; Victoria Pham; Helen S Booler; Linda Rangell; Sheila Ulufatu; Guy Salvesen; Jennie Lill; Menno Van Lookeren Campagne; Amos Baruch

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2441. doi:

Advertisement